Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cephagraine
- Development stage
- Unknown
- Lead developer
- Charak
- Administration
- Intranasal, Oral
01
Overview
Cephagraine is a proprietary Ayurvedic herbal formulation developed by Charak. It is available in two dosage forms: oral tablets and nasal drops (nasya). Cephagraine is primarily indicated for the management of migraine and sinusitis. The formulation contains a blend of traditional Ayurvedic herbs and minerals, including Pippali (Piper longum), Arka phool (Calotropis gigantea), Shuddha Godanti (purified gypsum), Dhattura (Datura metel), Ajmoda (Carum copticum), Sajjikhar (sodium carbonate), Bhringaraj (Eclipta alba), and Shunthi (Zingiber officinale). In migraine, Cephagraine acts as an analgesic and anti-inflammatory agent, helping to constrict dilated cranial blood vessels and reduce the frequency, severity, and duration of migraine attacks, as well as associated symptoms like nausea, vomiting, and tinnitus. In sinusitis, it acts as a decongestant, reducing inflammation of the nasal mucosa, liquefying mucus, and promoting easy breathing.
- Brand names
- CephagraineCephagraine Nasal DropsCephagraine Tablet
Beyond the preview
Go deeper on Cephagraine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cephagraine.